News
Oral Contraceptive Recalled
August 09, 2019
The recall affects Kaitlib Fe tablets from lot L800050. The tablets were distributed throughout the United States.
Lupin Pharmaceuticals Inc. voluntarily initiated the recall July 2, 2019. On July 30, 2019, the FDA designated the recall Class II. The classification suggests use of the product could cause temporary or medically reversible adverse health consequences. Although the likelihood is remote, a possibility of serious harm also exists.
Kaitlib Fe is a prescription oral contraceptive.
—Jolynn Tumolo